Literature DB >> 10908001

A multisite study of the effectiveness of methamphetamine treatment: an initiative of the Center for Substance Abuse Treatment.

J M Herrell1, J A Taylor, C Gallagher, S Dawud-Noursi.   

Abstract

In 1998, responding to national and regional epidemiological data indicating that methamphetamine (MA) abuse was a growing problem in the United States, the Center for Substance Abuse Treatment (CSAT) initiated a multisite MA treatment study. Through a collaborative approach among CSAT, seven treatment sites, and a coordinating center, the study compares the clinical and cost effectiveness of a manualized, cognitive-behavioral outpatient treatment developed by the Matrix Center in Los Angeles to the treatment approaches currently employed by the treatment sites. The study also explores technology transfer issues associated with integrating the Matrix approach within existing treatment settings. CSAT's approach to the initiation and management of this type of study is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908001     DOI: 10.1080/02791072.2000.10400222

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  5 in total

1.  Strategies to encourage adoption in multisite clinical trials.

Authors:  Joseph Guydish; Barbara Tajima; Sarah Turcotte Manser; Martha Jessup
Journal:  J Subst Abuse Treat       Date:  2006-11-22

2.  Multi-level assessment protocol (MAP) for adoption in multi-site clinical trials.

Authors:  J Guydish; S T Manser; M Jessup; B Tajima; C Sears; T Montini
Journal:  J Drug Issues       Date:  2005-07-01

3.  The relationship between methamphetamine use and increased dental disease.

Authors:  Vivek Shetty; Larissa J Mooney; Corwin M Zigler; Thomas R Belin; Debra Murphy; Richard Rawson
Journal:  J Am Dent Assoc       Date:  2010-03       Impact factor: 3.634

4.  Process-of-care measures as predictors of client outcome among a methamphetamine-dependent sample at 12- and 36-month follow-ups.

Authors:  Richard A Rawson; Rachel Gonzales; Lisa Greenwell; Mady Chalk
Journal:  J Psychoactive Drugs       Date:  2012 Sep-Oct

5.  Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders.

Authors:  Takayuki Harada; Hiroshi Tsutomi; Rintaro Mori; David B Wilson
Journal:  Cochrane Database Syst Rev       Date:  2018-12-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.